Solid-phase immunoglobulins IgG and IgM activate macrophages with solid-phase IgM acting via a novel scavenger receptor a pathway

American Journal of Pathology

Volumn 181, Issue 1, 2012, Pages 347-361

  Boyle, Joseph J ^a   Christou, Ivy ^b   Iqbal, M Bilal ^a   Nguyen, Aivi T ^a   Leung, Viola W Y ^a   Evans, Paul C ^a   Liu, Yu ^a   Johns, Michael ^a   Kirkham, Paul ^a   Haskard, Dorian O ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR A; SYNAPTOTAGMIN I; THROMBOPLASTIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANIMALS; BLOOD COAGULATION; CELLS, CULTURED; COMPLEMENT SYSTEM PROTEINS; CORONARY ARTERY DISEASE; CYTOTOXICITY, IMMUNOLOGIC; GPI-LINKED PROTEINS; HUMANS; HYDROGEN PEROXIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPROTEINS, LDL; MACROPHAGE ACTIVATION; MICE; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; PLAQUE, ATHEROSCLEROTIC; PROTEIN DENATURATION; RECEPTORS, FC; RECEPTORS, IGG; SCAVENGER RECEPTORS, CLASS A; SIGNAL TRANSDUCTION; THROMBOPLASTIN;

EID: 84862668282     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.03.040     Document Type: Article

References (54)

1. Lewis MJ, Malik TH, Ehrenstein MR, Boyle JJ, Botto M, Haskard DO: Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2009, 120:417-426
2. Kyaw T, Tay C, Khan A, Dumouchel V, Cao A, To K, Kehry M, Dunn R, Agrotis A, Tipping P, Bobik A, Toh BH: Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 2010, 185:4410-4419
3. Ravetch JV, Bolland S: IgG Fc receptors. Annu Rev Immunol 2001, 19:275-290
4. Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, Mangion J, Roberton-Lowe C, Marshall AJ, Petretto E, Hodges MD, Bhangal G, Patel SG, Sheehan-Rooney K, Duda M, Cook PR, Evans DJ, Domin J, Flint J, Boyle JJ, Pusey CD, Cook HT: Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 2006, 439:851-855
5. Boyle JJ: Human macrophages kill human mesangial cells by Fas-L-induced apoptosis when triggered by antibody via CD16. Clin Exp Immunol 2004, 137:529-537
6. Kelly JA, Griffin ME, Fava RA, Wood SG, Bessette KA, Miller ER, Huber SA, Binder CJ, Witztum JL, Morganelli PM. Inhibition of arterial lesion progression in CD16-deficient mice: evidence for altered immunity and the role of IL-10. Cardiovasc Res 2010, 85:224-231
7. Hartvigsen K, Chou MY, Hansen LF, Shaw PX, Tsimikas S, Binder CJ, Witztum JL. The role of innate immunity in atherogenesis. J Lipid Res 2009, 50(Suppl):S388-S393
8. Audard V, Georges B, Vanhille P, Toly C, Deroure B, Fakhouri F, Cuvelier R, Belenfant X, Surin B, Aucouturier P, Mougenot B, Ronco P: Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum. Clin J Am Soc Nephrol 2008, 3:1339-1349
9. Carroll MC, Holers VM: Innate autoimmunity. Adv Immunol 2005, 86:137-157
10. Zhang M, Michael LH, Grosjean SA, Kelly RA, Carroll MC, Entman ML: The role of natural IgM in myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 2006, 41:62-67
11. Kulik L, Fleming SD, Moratz C, Reuter JW, Novikov A, Chen K, Andrews KA, Markaryan A, Quigg RJ, Silverman GJ, Tsokos GC, Holers VM: Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury. J Immunol 2009, 182:5363-5373
12. Shi T, Moulton VR, Lapchak PH, Deng GM, le Lucca JJ, Tsokos GC: Ischemia-mediated aggregation of the actin cytoskeleton is one of the major initial events resulting in ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2009, 296:G339-G347
13. Binder CJ, Shaw PX, Chang MK, Boullier A, Hartvigsen K, Horkko S, Miller YI, Woelkers DA, Corr M, Witztum JL: The role of natural antibodies in atherogenesis. J Lipid Res 2005, 46:1353-1363
14. Boyle JJ: Association of coronary plaque rupture and atherosclerotic inflammation. J Pathol 1997, 181:93-99
15. Horkko S, Bird DA, Miller E, Itabe H, Leitinger N, Subbanagounder G, Berliner JA, Friedman P, Dennis EA, Curtiss LK, Palinski W, Witztum JL: Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 1999, 103:117-128
16. Kyaw T, Tay C, Krishnamurthi S, Kanellakis P, Agrotis A, Tipping P, Bobik A, Toh BH. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res 2011, 109:830-840
17. Shah PK: Molecular mechanisms of plaque instability. Curr Opin Lipidol 2007, 18:492-499
18. Littlewood TD, Bennett MR: Apoptotic cell death in atherosclerosis. Curr Opin Lipidol 2003, 14:469-475
19. de Winther MP, van Dijk KW, Havekes LM, Hofker MH: Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis. Arterioscler Thromb Vasc Biol 2000, 20:290-297
20. Wung BS, Cheng JJ, Hsieh HJ, Shyy YJ, Wang DL: Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1. Circ Res 1997, 81:1-7
21. Mietus-Snyder M, Friera A, Glass CK, Pitas RE: Regulation of scavenger receptor expression in smooth muscle cells by protein kinase C: a role for oxidative stress. Arterioscler Thromb Vasc Biol 1997, 17:969-978
22. Boyle JJ: Human macrophages kill human mesangial cells by Fas-L-induced apoptosis when triggered by antibody via CD16. Clin Exp Immunol 2004, 137:529-537
23. Lund I, Lundeberg T, Sandberg L, Budh CN, Kowalski J, Svensson E: Lack of interchangeability between visual analogue and verbal rating pain scales: a cross sectional description of pain etiology groups. BMC Med Res Methodol 2005, 5:31
24. Boyle JJ, Harrington HA, Piper E, Elderfield K, Stark J, Landis RC, Haskard DO: Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am J Pathol 2009, 174:1097-108
25. Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, Mangion J, Roberton-Lowe C, Marshall AJ, Petretto E, Hodges MD, Bhangal G, Patel SG, Sheehan-Rooney K, Duda M, Cook PR, Evans DJ, Domin J, Flint J, Boyle JJ, Pusey CD, Cook HT: Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 2006, 439:851-855
26. Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J, Hendrick AG, Carlton MB, Greaves DR: Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med 2008, 205:767-775
27. Boyle JJ, Weissberg PL, Bennett MR: Human macrophage-induced vascular smooth muscle cell apoptosis requires NO enhancement of Fas/Fas-L interactions. Arterioscler Thromb Vasc Biol 2002, 22:1624-1630
28. Leung VW, Yun S, Botto M, Mason JC, Malik TH, Song W, Paixao-Cavalcante D, Pickering MC, Boyle JJ, Haskard DO: Decay-accelerating factor suppresses complement C3 activation and retards atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol 2009, 175:1757-1767
29. Boyle JJ, Johns M, Kampfer T, Nguyen AT, Game L, Schaer DJ, Mason JC, Haskard DO. Activating Transcription Factor 1 directs Mhem atheroprotective macrophages via coordinated iron handling and foam cell protection. Circ Res 2012, (in press)
30. Boyle JJ, Bowyer DE, Weissberg PL, Bennett MR: Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions. Arterioscler Thromb Vasc Biol 2001, 21:1402-1407
31. Boyle JJ, Weissberg PL, Bennett MR: Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms. Arterioscler Thromb Vasc Biol 2003, 23:1553-1558
32. Dai Y, Pei XY, Rahmani M, Conrad DH, Dent P, Grant S: Interruption of the NF-kappaB pathway by Bay 11-7082 promotes UCN-01-mediated mitochondrial dysfunction and apoptosis in human multiple myeloma cells. Blood 2004, 103:2761-2770
33. Hansson GK, Libby P: The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006, 6:508-519
34. Hansson GK, Libby P, Schonbeck U, Yan ZQ: Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002, 91:281-291
35. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W, Jr., Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003, 108:1664-1672
36. Bjorkerud S, Bjorkerud B: Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 1996, 149:367-380
37. Greaves DR, Gordon S. The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges. J Lipid Res 2009;50(Suppl):S282- S286
38. Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, Shaw PX, Choi J, Perkmann T, Backhed F, Miller YI, Horkko S, Corr M, Witztum JL, Binder CJ: Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 2009, 119:1335-1349
39. de Winther MP, Hofker MH: Scavenging new insights into atherogenesis. J Clin Invest 2000, 105:1039-1041
40. Witztum JL. You are right too! J Clin Invest 2005, 115:2072-2075
41. Kirkham PA, Spooner G, Ffoulkes-Jones C, Calvez R: Cigarette smoke triggers macrophage adhesion and activation: role of lipid peroxidation products and scavenger receptor. Free Radic Biol Med 2003, 35:697-710
42. Platt N, Gordon S: Is the class A macrophage scavenger receptor (SR-A) multifunctional? - the mouse's tale. J Clin Invest 2001, 108:649-654
43. Guicciardi ME, Gores GJ: Life and death by death receptors. FASEB J 2009, 23:1625-1637
44. Werb Z, Takemura R, Stenberg PE, Bainton DF: Directed exocytosis of secretory granules containing apolipoprotein E to the adherent surface and basal vacuoles of macrophages spreading on immobile immune complexes. Am J Pathol 1989, 134:661-670
45. Schwartz SM, Virmani R, Rosenfeld ME: The good smooth muscle cells in atherosclerosis. Curr Atheroscler Rep 2000, 2:422-429
46. Imanishi T, Han DK, Hofstra L, Hano T, Nishio I, Liles WC, Gown AM, Schwartz SM: Apoptosis of vascular smooth muscle cells is induced by Fas ligand derived from monocytes/macrophage. Atherosclerosis 2002, 161:143-151
47. Vasudevan SS, Lopes NH, Seshiah PN, Wang T, Marsh CB, Kereiakes DJ, Dong C, Goldschmidt-Clermont PJ: Mac-1 and Fas activities are concurrently required for execution of smooth muscle cell death by M-CSF-stimulated macrophages. Cardiovasc Res 2003, 59:723-733
48. Hansson GK, Bondjers G, Nilsson LA: Plasma protein accumulation in injured endothelial cells. Immunofluorescent localization of IgG and fibrinogen in the rabbit aortic endothelium. Exp Mol Pathol 1979, 30:12-26
49. Hansson GK, Bondjers G, Bylock A, Hjalmarsson L: Ultrastructural studies on the localization of IgG in the aortic endothelium and subendothelial intima of atherosclerotic and nonatherosclerotic rabbits. Exp Mol Pathol 1980, 33:302-315
50. Hansson GK, Holm J, Kral JG: Accumulation of IgG and complement factor C3 in human arterial endothelium and atherosclerotic lesions. Acta Pathol Microbiol Immunol Scand A 1984, 92:429-435
51. Seifert PS, Hansson GK: Complement receptors and regulatory proteins in human atherosclerotic lesions. Arteriosclerosis 1989, 9:802-811
52. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W, Jr., Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 2003, 108: 1772-1778
53. Kramer MC, van der Wal AC, Koch KT, Rittersma SZ, Li X, Ploegmakers HP, Henriques JP, Van der Schaaf RJ, Baan J, Jr., Vis MM, Meesterman MG, Piek JJ, Tijssen JG, De Winter RJ: Histopathological features of aspirated thrombi after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. PLoS ONE 2009, 4:e5817
54. Bennett MR: Breaking the plaque: evidence for plaque rupture in animal models of atherosclerosis. Arterioscler Thromb Vasc Biol 2002, 22:713-714